SONOSCAPE MEDICAL CORP.

Sonoscape Medical Corp. specializes in ultrasound-related medical devices, including handheld extracorporeal ultrasound imaging transducers for various applications like rectal, vaginal, oesophageal, and surgical use. Their portfolio also includes reusable oesophageal ultrasound transducers, general-purpose ultrasound imaging systems, and endoscopic accessories such as line-powered light sources and video processing units. These devices are designed to support high-resolution imaging and endoscopic procedures.

Sonoscape Medical Corp. is based in China. While the country of origin does not inherently determine regulatory classification, it influences compliance requirements for global markets. The company’s devices are listed in key regulatory databases like eudamed (EU), FDA 510(k), and FDA UDI (US), ensuring they meet the necessary standards for market authorization in those regions.

Sonoscape Medical Corp.’s devices are listed in eudamed (for EU compliance), FDA 510(k) (for US premarket submissions), and FDA UDI (for unique device identification). Listing in these databases is critical because it provides transparency for regulators, healthcare providers, and patients, ensuring traceability and compliance with global medical device regulations. It also supports post-market surveillance and risk management processes.

Sonoscape Medical Corp.’s devices fall under EU Medical Device Regulations classifications of Class I, Class II, Class IIa, and Class IIb. The classification depends on factors like intended use, risk level, and interaction with the body—for example, surgical ultrasound transducers may carry higher risk and thus a stricter classification. In the US, similar risk-based categorization applies, though the exact FDA classification (e.g., Class I, II, or III) may differ from the EU system. These classifications determine the regulatory pathway for market authorization.

Checking listings in eudamed or FDA databases ensures that a device has undergone the necessary regulatory processes to be legally marketed in the EU or US. For healthcare providers, this confirms the device’s compliance with safety and performance standards. For regulators, it validates that the manufacturer has met reporting obligations, such as UDI registration, which aids in tracking recalls, adverse events, and post-market surveillance. This transparency builds trust in the device’s legitimacy and safety.